Filter
384
Text search:
antimicrobial
susceptibility
testing
Featured
Recommendations
53
New Publications
87
Language
Document type
No document type
138
Studies & Reports
99
Guidelines
95
Strategic & Response Plan
23
Manuals
15
Training Material
6
Situation Updates
6
Online Courses
1
Fact sheets
1
Countries / Regions
India
22
South Africa
15
Ethiopia
13
Kenya
12
Africa
8
Philippines
7
Western and Central Europe
7
Nigeria
6
Global
6
Zimbabwe
5
Nepal
5
Malawi
5
Latin America and the Carribbean
5
Asia
5
Ghana
4
Tanzania
4
Ukraine
4
Eastern Europe
4
Sierra Leone
3
Cameroon
3
Uganda
3
Zambia
3
Eswatini/ Swaziland
3
Western Pacific Region
3
Russia
3
Burkina Faso
2
Pakistan
2
Cambodia
2
Rwanda
2
Laos
2
Gabon
2
Liberia
1
Senegal
1
USA
1
Saudi Arabia
1
Iraq
1
Jordan
1
Afghanistan
1
Thailand
1
China
1
Bangladesh
1
Mozambique
1
Sudan
1
Peru
1
Brazil
1
Botswana
1
Libya
1
Myanmar / Burma
1
East and Southern Africa
1
Fiji
1
Bhutan
1
Vietnam
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
106
Clinical Guidelines
53
Pharmacy & Technologies
13
Women & Child Health
12
Public Health
9
Key Resources
9
Capacity Building
3
Toolboxes
AMR
172
TB
51
HIV
22
Rapid Response
17
Cholera
10
Planetary Health
9
COVID-19
8
Ebola
7
Refugee
6
Pharmacy
6
Conflict
4
NTDs
4
Caregiver
3
Natural Hazards
2
Global Health Education
2
Polio
1
Mental Health
1
NCDs
1
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
Policy framework.
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Washington, D.C., USA, 23-27 September 2018
Provisional Agenda Item 4.6
CD56/10, Rev. 1 31 August 2018
Original: Spanish
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re
...
This Global Plan builds on the previous edition, which laid out priority actions for 2018-2022, informed by global commitments member states endorsed at the 2018 United Nations High-Level Meeting (UNHLM) on TB. The resource needs estimates from this Global Plan include resources needed for implement
...
